Marco Matos1, Hai-Ying Shen2, Elisabete Augusto1, Yumei Wang3, Catherine J Wei3, Yu Tian Wang4, Paula Agostinho5, Detlev Boison2, Rodrigo A Cunha5, Jiang-Fan Chen6. 1. Department of Neurology, Boston University School of Medicine, Boston, Massachusetts; Center for Neuroscience and Cell Biology, University of Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Portugal. 2. R.S. Dow Neurobiology Laboratories, Legacy Research Institute, Portland, Oregon. 3. Department of Neurology, Boston University School of Medicine, Boston, Massachusetts. 4. Department of Neurology, Boston University School of Medicine, Boston, Massachusetts; Department of Medicine and Brain Research Centre, Vancouver Hospital and Health Sciences Centre, University of British Columbia, Vancouver, Canada. 5. Center for Neuroscience and Cell Biology, University of Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Portugal. 6. Department of Neurology, Boston University School of Medicine, Boston, Massachusetts. Electronic address: chenjf@bu.edu.
Abstract
BACKGROUND: Adenosine A2A receptors (A2AR) modulate dopamine and glutamate signaling and thereby may influence some of the psychomotor and cognitive processes associated with schizophrenia. Because astroglial A2AR regulate the availability of glutamate, we hypothesized that they might play an unprecedented role in some of the processes leading to the development of schizophrenia, which we investigated using a mouse line with a selective deletion of A2AR in astrocytes (Gfa2-A2AR knockout [KO] mice]. METHODS: We examined Gfa2-A2AR KO mice for behaviors thought to recapitulate some features of schizophrenia, namely enhanced MK-801 psychomotor response (positive symptoms) and decreased working memory (cognitive symptoms). In addition, we probed for neurochemical alterations in the glutamatergic circuitry, evaluating glutamate uptake and release and the levels of key proteins defining glutamatergic signaling (glutamate transporter-I [GLT-I], N-methyl-D-aspartate receptors [NMDA-R] and α-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors [AMPA-R]) to provide a mechanistic understanding of the phenotype encountered. RESULTS: We show that Gfa2-A2AR KO mice exhibited enhanced MK-801 psychomotor response and decreased working memory; this was accompanied by a disruption of glutamate homeostasis characterized by aberrant GLT-I activity, increased presynaptic glutamate release, NMDA-R 2B subunit upregulation, and increased internalization of AMPA-R. Accordingly, selective GLT-I inhibition or blockade of GluR1/2 endocytosis prevented the psychomotor and cognitive phenotypes in Gfa2-A2AR KO mice, namely in the nucleus accumbens. CONCLUSIONS: These results show that the dysfunction of astrocytic A2AR, by controlling GLT-I activity, triggers an astrocyte-to-neuron wave of communication resulting in disrupted glutamate homeostasis, thought to underlie several endophenotypes relevant to schizophrenia.
BACKGROUND: Adenosine A2A receptors (A2AR) modulate dopamine and glutamate signaling and thereby may influence some of the psychomotor and cognitive processes associated with schizophrenia. Because astroglial A2AR regulate the availability of glutamate, we hypothesized that they might play an unprecedented role in some of the processes leading to the development of schizophrenia, which we investigated using a mouse line with a selective deletion of A2AR in astrocytes (Gfa2-A2AR knockout [KO] mice]. METHODS: We examined Gfa2-A2AR KO mice for behaviors thought to recapitulate some features of schizophrenia, namely enhanced MK-801psychomotor response (positive symptoms) and decreased working memory (cognitive symptoms). In addition, we probed for neurochemical alterations in the glutamatergic circuitry, evaluating glutamate uptake and release and the levels of key proteins defining glutamatergic signaling (glutamate transporter-I [GLT-I], N-methyl-D-aspartate receptors [NMDA-R] and α-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors [AMPA-R]) to provide a mechanistic understanding of the phenotype encountered. RESULTS: We show that Gfa2-A2AR KO mice exhibited enhanced MK-801psychomotor response and decreased working memory; this was accompanied by a disruption of glutamate homeostasis characterized by aberrant GLT-I activity, increased presynaptic glutamate release, NMDA-R 2B subunit upregulation, and increased internalization of AMPA-R. Accordingly, selective GLT-I inhibition or blockade of GluR1/2 endocytosis prevented the psychomotor and cognitive phenotypes in Gfa2-A2AR KO mice, namely in the nucleus accumbens. CONCLUSIONS: These results show that the dysfunction of astrocytic A2AR, by controlling GLT-I activity, triggers an astrocyte-to-neuron wave of communication resulting in disrupted glutamate homeostasis, thought to underlie several endophenotypes relevant to schizophrenia.
Authors: Elena Bastia; Yue-Hang Xu; Angela C Scibelli; Yuan-Ji Day; Joel Linden; Jiang-Fan Chen; Michael A Schwarzschild Journal: Neuropsychopharmacology Date: 2005-05 Impact factor: 7.853
Authors: Karen Brebner; Tak Pan Wong; Lidong Liu; Yitao Liu; Paul Campsall; Sarah Gray; Lindsay Phelps; Anthony G Phillips; Yu Tian Wang Journal: Science Date: 2005-11-25 Impact factor: 47.728
Authors: Hai-Ying Shen; Joana E Coelho; Nobuhisa Ohtsuka; Paula M Canas; Yuan-Ji Day; Qing-Yuan Huang; Nelson Rebola; Liqun Yu; Detlev Boison; Rodrigo A Cunha; Joel Linden; Joe Z Tsien; Jiang-Fan Chen Journal: J Neurosci Date: 2008-03-19 Impact factor: 6.167
Authors: Liqun Yu; Hai-Ying Shen; Joana E Coelho; Inês M Araújo; Qing-Yuan Huang; Yuan-Ji Day; Nelson Rebola; Paula M Canas; Erica Kirsten Rapp; Jarrod Ferrara; Darcie Taylor; Christa E Müller; Joel Linden; Rodrigo A Cunha; Jiang-Fan Chen Journal: Ann Neurol Date: 2008-03 Impact factor: 10.422
Authors: Charles B Mikell; Guy M McKhann; Solomon Segal; Robert A McGovern; Matthew B Wallenstein; Holly Moore Journal: Stereotact Funct Neurosurg Date: 2009-06-26 Impact factor: 1.875
Authors: A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich Journal: Mol Psychiatry Date: 2017-09-26 Impact factor: 15.992
Authors: Cassidy L Moody; Adam J Funk; Emily Devine; Ryan C Devore Homan; Detlev Boison; Robert E McCullumsmith; Sinead M O'Donovan Journal: Schizophr Bull Date: 2020-04-10 Impact factor: 9.306
Authors: D M Osborne; U S Sandau; A T Jones; J W Vander Velden; A M Weingarten; N Etesami; Y Huo; H Y Shen; D Boison Journal: Neuropharmacology Date: 2018-08-23 Impact factor: 5.250